+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)

Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)

Neurobiology of Aging 55: 123-131

Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative condition characterized by loss of motor neurones and progressive muscle wasting. There is no diagnostic test for ALS therefore robust biomarkers would not only be valuable for diagnosis, but also for the classification of disease subtypes, monitoring responses to drugs and tracking disease progression. As regulators of gene expression, microRNAs (miRNAs) are increasingly used for diagnostic and prognostic purposes in various disease states with increasing exploration in neurodegenerative disorders. We hypothesize that circulating blood-based miRNAs will serve as biomarkers and use miRNA profiling to determine miRNA signatures from the serum of sporadic ALS patients compared to healthy controls and patients with diseases that mimic ALS. A number of differentially expressed miRNAs were identified in each set of patient comparisons. Validation in an additional patient cohort showed that miR-206 and miR-143-3p were increased and miR-374b-5p was decreased compared to controls. A continued change in miRNA expression persisted during disease progression indicating the potential use of these particular miRNAs as longitudinal biomarkers in ALS.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 060240624

Download citation: RISBibTeXText

PMID: 28454844

DOI: 10.1016/j.neurobiolaging.2017.03.027

Related references

Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients. Neuromolecular Medicine 18(4): 551-560, 2016

ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis. Journal of Neurology 260(7): 1782-1797, 2013

MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis. Journal of Molecular Neuroscience 56(1): 102-112, 2015

Potential utility of biomarkers in the diagnosis and treatment of amyotrophic lateral sclerosis. Clinical Investigation 2(1): 107-117, 2012

Gelsolin, clusterin and cd5l are the potential plasma biomarkers of amyotrophic lateral sclerosis with and without cognitive impairment. Journal of Neurology Neurosurgery & Psychiatry 88(5): E1.31-E1, 2017

Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiology of Aging 64: 123-138, 2018

Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadic amyotrophic lateral sclerosis. Disease Markers 32(4): 211-220, 2012

Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. Journal of the Neurological Sciences 348(1-2): 245-250, 2015

Blood volatile organic compounds as potential biomarkers for amyotrophic lateral sclerosis: an animal study in the SOD1 G93A mouse. Journal of Molecular Neuroscience 55(1): 167-173, 2015

Capillary electrophoresis tandem mass spectrometry determination of glutamic acid and homocysteine's metabolites: Potential biomarkers of amyotrophic lateral sclerosis. Talanta 170: 63-68, 2017

Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 9: 69, 2016

Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiology of Disease 49: 107-117, 2013

Visualization and Analysis of miRNAs Implicated in Amyotrophic Lateral Sclerosis Within Gene Regulatory Pathways. Studies in Health Technology and Informatics 253: 183-187, 2018

Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis). Neurologic Clinics 33(4): 775-785, 2015

Biomarkers for amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 6(3): 387-398, 2006